UNITY MEDICAL ACADEMY

ADULT HEALTH NURSING – I

EMPHYSEMA

Complete Nursing Notes + NORCET MCQ Practice Test

1. Definition

Emphysema is a chronic lung condition characterized by abnormal permanent enlargement of airspaces distal to the terminal bronchioles with destruction of their walls, without obvious fibrosis. It is commonly associated with COPD.

NORCET High-Yield:
Emphysema → alveolar wall destruction + loss of elastic recoil + air trapping + hyperinflation.

2. Etiology and Risk Factors

Major Risk Factors

Cigarette smoking
Passive smoke exposure
Long-term exposure to air pollutants
Occupational dust and chemical exposure
Repeated respiratory irritation
Genetic susceptibility
Alpha-1 antitrypsin deficiency

Important: Smoking is the most important preventable risk factor for the common smoking-related form of emphysema.

3. Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin (AAT) is a protective protein that helps inhibit proteolytic enzymes such as neutrophil elastase.

Alpha-1 Antitrypsin Deficiency
↓
Reduced protection against proteolytic enzymes
↓
Increased alveolar tissue destruction
↓
Emphysema

Exam Point: AAT deficiency is an important inherited risk factor for emphysema, particularly when emphysema occurs at a relatively young age or with a limited smoking history.

4. Pathophysiology

Chronic exposure to harmful particles
↓
Chronic inflammatory response
↓
Protease–antiprotease imbalance + oxidative stress
↓
Alveolar wall destruction
↓
Loss of elastic recoil
↓
Small airway collapse during expiration
↓
Air trapping
↓
Hyperinflation
↓
Increased work of breathing
↓
Ventilation-perfusion abnormalities
↓
Impaired gas exchange

5. Major Pathological Changes

A. Alveolar Wall Destruction

The walls between adjacent alveoli are destroyed, resulting in enlarged airspaces and reduced effective gas-exchange surface area.

B. Loss of Elastic Recoil

Destruction of elastic tissue decreases the lung's ability to recoil during expiration.

C. Small Airway Collapse

During expiration, reduced radial traction and loss of elastic recoil allow small airways to collapse more easily.

D. Air Trapping

Air becomes trapped because the patient cannot completely empty the lungs during expiration.

E. Hyperinflation

Persistent air trapping increases lung volumes and may produce a barrel-shaped chest.

F. Reduced Gas-Exchange Surface

Destruction of alveolar walls reduces the surface area available for oxygen and carbon dioxide exchange.

6. Types / Patterns of Emphysema

Pattern	Important Features
Centriacinar	Predominantly affects respiratory bronchioles. Strongly associated with cigarette smoking and often more prominent in upper lung regions.
Panacinar	Involves the entire acinus more uniformly. Classically associated with alpha-1 antitrypsin deficiency and often has a lower-lung predominance.
Paraseptal	More prominent near pleural surfaces and interlobular septa; may be associated with bullae and spontaneous pneumothorax.

NORCET Memory:
Smoking → Centriacinar
AAT deficiency → Panacinar

7. Clinical Manifestations

Early Symptoms

Progressive exertional dyspnea
Reduced exercise tolerance
Dry or minimally productive cough
Fatigue

Advanced Symptoms

Severe dyspnea
Prolonged expiration
Accessory muscle use
Hyperinflation
Barrel-shaped chest
Weight loss
Muscle wasting
Exercise intolerance
Possible hypoxemia

8. Physical Examination Findings

Finding	Reason / Significance
Barrel chest	Chronic hyperinflation
Reduced breath sounds	Reduced airflow and hyperinflation
Prolonged expiration	Difficulty emptying the lungs
Use of accessory muscles	Increased work of breathing
Hyperresonance	May occur because of increased air volume
Weight loss	Increased work of breathing and reduced intake may contribute

9. Why Does Dyspnea Occur?

Dyspnea in emphysema results from several interacting mechanisms:

Air trapping
Hyperinflation
Reduced elastic recoil
Increased work of breathing
Reduced effective alveolar surface area
Ventilation-perfusion abnormalities
Respiratory muscle disadvantage caused by hyperinflation

Clinical concept: The patient may feel that they cannot "get enough air" because hyperinflation makes further inspiration mechanically difficult.

10. Diagnosis and Investigations

1. Spirometry

Spirometry is central to confirming persistent airflow obstruction when COPD is suspected.

Parameter	Finding / Meaning
FEV₁	May be reduced because of airflow limitation
FVC	May be normal or reduced depending on severity and hyperinflation
FEV₁/FVC	Reduced in persistent airflow obstruction

2. Chest X-ray

Possible findings include:

Hyperinflation
Flattened diaphragms
Increased retrosternal airspace
Long, narrow cardiac silhouette in some patients

3. CT Chest

CT can demonstrate emphysematous changes, bullae and their distribution when clinically indicated.

4. Arterial Blood Gas

ABG may be used in patients with significant disease or acute deterioration to assess oxygenation and ventilation.

5. Alpha-1 Antitrypsin Testing

Consider testing in appropriate patients, particularly those with early-onset emphysema or a relevant family history.

11. Medical Management

A. Smoking Cessation

Assess tobacco use.
Provide counseling and behavioral support.
Offer appropriate pharmacological cessation support when indicated.
Encourage avoidance of secondhand smoke.

B. Bronchodilators

Short-acting bronchodilators: May provide rapid symptom relief when prescribed.

LABA: Long-acting beta₂ agonists provide prolonged bronchodilation for maintenance therapy in appropriate COPD patients.

LAMA: Long-acting muscarinic antagonists provide prolonged bronchodilation and are important maintenance medications in COPD.

LABA + LAMA: Dual long-acting bronchodilation may be used when additional symptom control is required.

C. Inhaled Corticosteroids

ICS may be used in selected COPD patients based on clinical characteristics, particularly exacerbation history and other indications.

D. Oxygen Therapy

Long-term oxygen therapy may be indicated for selected patients with severe chronic hypoxemia after appropriate assessment.

In patients at risk for hypercapnic respiratory failure, oxygen should be titrated according to the prescribed target and clinical/ABG monitoring.

12. Pulmonary Rehabilitation

Pulmonary rehabilitation is an important component of comprehensive COPD management.

Exercise training
Breathing strategies
Education
Self-management
Energy conservation
Nutritional support when required

The goal is to improve functional capacity, symptom management and quality of life rather than simply treating one isolated respiratory symptom.

13. Pursed-Lip Breathing

Relax the shoulders and neck.
Inhale slowly through the nose.
Purse the lips gently.
Exhale slowly through the partially closed lips.
Make expiration longer than inspiration.

Purpose: Prolonged expiration helps maintain airway pressure and may reduce dynamic airway collapse and air trapping.

14. Diaphragmatic Breathing

Place one hand on the chest and one on the abdomen.
Inhale slowly through the nose.
Allow the abdomen to rise during inspiration.
Keep upper chest movement relatively relaxed.
Exhale slowly.

15. Nursing Management

A. Respiratory Assessment

Monitor respiratory rate and pattern.
Assess respiratory effort.
Monitor breath sounds.
Observe use of accessory muscles.
Monitor SpO₂ as prescribed.
Assess ability to speak and perform activities.
Monitor mental status during deterioration.

B. Positioning

Keep the patient in a comfortable upright position.
High-Fowler's position may improve lung expansion.
Allow forward-leaning supported positioning if it relieves dyspnea.

C. Breathing Support

Teach pursed-lip breathing.
Encourage controlled breathing during exertion.
Reduce anxiety-provoking environmental stimuli.
Allow adequate rest periods.

D. Oxygen Monitoring

Administer oxygen as prescribed.
Monitor response to oxygen therapy.
Monitor for deterioration.
Review ABG results when available.

16. Nutritional Management

Monitor weight and nutritional status.
Provide small, frequent meals when appropriate.
Allow rest before meals.
Encourage adequate energy and protein intake.
Maintain appropriate hydration unless contraindicated.

Severe dyspnea increases the energy cost of breathing. Poor nutritional status can contribute to respiratory muscle weakness and reduced functional capacity.

17. Energy Conservation

Plan activities in advance.
Alternate activity with rest.
Sit during activities whenever possible.
Keep frequently used objects nearby.
Avoid unnecessary rushing.
Use prescribed breathing techniques during exertion.

18. Complications

Progressive airflow limitation
Acute COPD exacerbations
Respiratory failure
Pulmonary hypertension
Cor pulmonale
Recurrent respiratory infections
Severe hyperinflation
Weight loss and muscle wasting
Spontaneous pneumothorax, particularly with bullous disease
Reduced exercise capacity

19. Bullous Emphysema and Pneumothorax

In some patients, areas of emphysematous destruction can form large air-filled spaces called bullae.

Rupture of a subpleural bulla can cause a spontaneous pneumothorax.

Clinical Warning: Sudden unilateral chest pain with sudden worsening of dyspnea in a patient with emphysema should prompt urgent assessment for possible pneumothorax.

20. Cor Pulmonale

Long-standing hypoxic pulmonary vasoconstriction and pulmonary vascular changes may contribute to pulmonary hypertension. In advanced disease, this can lead to right ventricular strain and cor pulmonale.

Possible Findings

Peripheral edema
Raised JVP
Fatigue
Worsening exercise tolerance
Right-sided heart failure features

21. Emphysema vs Chronic Bronchitis

Feature	Emphysema	Chronic Bronchitis
Primary pathology	Alveolar wall destruction	Chronic airway inflammation and mucus hypersecretion
Elastic recoil	Reduced	May be relatively preserved compared with emphysema
Air trapping	Prominent	May occur when significant airflow obstruction is present
Typical symptom	Prominent dyspnea	Prominent productive cough
Hyperinflation	Prominent	May occur
Secretions	Often less prominent	Usually increased

22. Emphysema vs Asthma

Feature	Emphysema/COPD	Asthma
Airflow limitation	Persistent in COPD	Usually variable
Elastic recoil	Reduced	Usually not the defining abnormality
Hyperinflation	Common	May occur during severe attacks
Symptoms	Often progressive	Often episodic/variable

23. Patient Education

Stop smoking.
Avoid secondhand smoke and respiratory irritants.
Use inhalers correctly.
Follow prescribed medication schedules.
Practice breathing exercises.
Maintain appropriate physical activity.
Attend pulmonary rehabilitation when prescribed.
Maintain adequate nutrition.
Recognize early worsening of symptoms.
Follow recommended vaccination advice.
Attend regular follow-up.

24. Emergency Warning Signs

Sudden severe dyspnea
Sudden unilateral chest pain
Marked increase in respiratory effort
Altered level of consciousness
Severe hypoxemia
Inability to speak comfortably because of breathlessness
Signs of respiratory failure

These findings require urgent clinical assessment and appropriate escalation.

25. NORCET High-Yield Points

Emphysema → permanent enlargement of distal airspaces with alveolar wall destruction.
Major consequence → loss of elastic recoil.
Loss of elastic recoil → expiratory airway collapse.
Expiratory airway collapse → air trapping.
Air trapping → hyperinflation.
Smoking → major risk factor for common emphysema.
Alpha-1 antitrypsin deficiency → important inherited risk factor.
Smoking-related pattern → centriacinar emphysema.
AAT deficiency → classically panacinar emphysema.
Typical clinical feature → progressive dyspnea.
Barrel chest → chronic hyperinflation.
Key COPD investigation → spirometry.
Reduced FEV₁/FVC → airflow obstruction.
Pursed-lip breathing → prolonged expiration.
Bullous disease → possible spontaneous pneumothorax.
Advanced disease → pulmonary hypertension and cor pulmonale may develop.

26. Quick Revision

Question	Answer
Main pathology?	Alveolar wall destruction
What is lost?	Elastic recoil
Main mechanical consequence?	Air trapping
Result of chronic air trapping?	Hyperinflation
Common symptom?	Progressive dyspnea
Typical chest finding?	Barrel-shaped chest
Major preventable risk factor?	Cigarette smoking
Inherited risk factor?	Alpha-1 antitrypsin deficiency
Smoking-related pattern?	Centriacinar
AAT deficiency pattern?	Panacinar
Breathing technique?	Pursed-lip breathing
Important complication of bullae?	Pneumothorax

EMPHYSEMA – NORCET MCQ PRACTICE TEST

25 Clinical & Concept-Based Questions

30:00

Time Limit: 30 Minutes

Question 1 of 25

Emphysema - Complete Notes With MCQs Practice